{"id":49980,"date":"2022-10-24T15:02:33","date_gmt":"2022-10-24T13:02:33","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/electromed-inc-appoints-brad-nagel-as-chief-financial-officer\/"},"modified":"2022-10-24T15:02:33","modified_gmt":"2022-10-24T13:02:33","slug":"electromed-inc-appoints-brad-nagel-as-chief-financial-officer","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/electromed-inc-appoints-brad-nagel-as-chief-financial-officer\/","title":{"rendered":"Electromed, Inc. Appoints Brad Nagel as Chief Financial Officer"},"content":{"rendered":"
\n

\nAccomplished medical device leader to fill key strategic role<\/i>\n<\/p>\n

NEW PRAGUE, Minn.–(BUSINESS WIRE)–Electromed, Inc. (\u201cElectromed\u201d or the \u201cCompany\u201d) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that its Board of Directors has appointed Brad Nagel as the Company\u2019s Chief Financial Officer, effective November 14, 2022.\n<\/p>\n

\nMr. Nagel brings to Electromed over fifteen years of financial leadership and strategic planning experience with Fortune 500 companies. Most recently, Mr. Nagel held the position of Divisional Chief Financial Officer of Global Lung Health and Visualization at Medtronic and was a key contributor in driving the unit\u2019s revenue growth. In that role, he served as the primary business partner to the General Manager and leadership team with a strategic focus on revenue growth, expense management, strategic product development and business development. Prior to his role as Divisional Chief Financial Officer, Mr. Nagel held various roles of increasing responsibility in finance, sales operations and accounting at Medtronic, Target Corporation and TCF Bank.\n<\/p>\n

\n\u201cWe are thrilled to welcome Brad to the Electromed team,\u201d Kathleen Skarvan, Electromed\u2019s President and Chief Executive Officer, commented. \u201cBrad is a dynamic financial executive with a superior track record of engineering growth and creating value in the medical device and retail industries. Through collaborative and cross-functional leadership, Brad has proven to be a high-impact leader with extensive background in developing high-performing teams. His financial, analytical and strategic acumen coupled with his leadership style makes Brad a strong cultural fit at this time when Electromed is poised for accelerating growth. I am confident he will be an excellent addition to the leadership team.\u201d\n<\/p>\n

\nSkarvan continued, \u201cI would also like to thank Michelle Wirtz for stepping into the Interim Chief Financial Officer role during our search for a permanent Chief Financial Officer. Michelle has done a tremendous job in the interim position, exemplifying the spirit and dedication of the Company, and will retain her existing role of Corporate Controller. I am grateful to have a talented and nimble team.\u201d\n<\/p>\n

\nMr. Nagel stated, \u201cI am delighted to join Electromed at a time of significant opportunity for the Company and its stakeholders. I look forward to working closely with the team to support Electromed\u2019s growth strategies and long-term success.\u201d\n<\/p>\n

\nAbout Electromed, Inc.<\/b>\n<\/p>\n

\nElectromed, Inc. manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest\u00ae Airway Clearance System, to patients with compromised pulmonary function. The Company is headquartered in New Prague, Minnesota and was founded in 1992. Further information about the Company can be found at www.smartvest.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMike Cavanaugh, Investor Relations
\n
ICR Westwicke
\n
(617) 877-9641
\n
mike.cavanaugh@westwicke.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Accomplished medical device leader to fill key strategic role NEW PRAGUE, Minn.–(BUSINESS WIRE)–Electromed, Inc. (\u201cElectromed\u201d or the \u201cCompany\u201d) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that its Board of Directors has appointed Brad Nagel as the Company\u2019s Chief Financial Officer, effective November 14, 2022. Mr. Nagel brings to Electromed over … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49980","6":"format-standard","7":"category-industry"},"yoast_head":"\nElectromed, Inc. Appoints Brad Nagel as Chief Financial Officer - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/electromed-inc-appoints-brad-nagel-as-chief-financial-officer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Electromed, Inc. Appoints Brad Nagel as Chief Financial Officer - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Accomplished medical device leader to fill key strategic role NEW PRAGUE, Minn.–(BUSINESS WIRE)–Electromed, Inc. (\u201cElectromed\u201d or the \u201cCompany\u201d) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that its Board of Directors has appointed Brad Nagel as the Company\u2019s Chief Financial Officer, effective November 14, 2022. Mr. Nagel brings to Electromed over ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/electromed-inc-appoints-brad-nagel-as-chief-financial-officer\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-24T13:02:33+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/electromed-inc-appoints-brad-nagel-as-chief-financial-officer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/electromed-inc-appoints-brad-nagel-as-chief-financial-officer\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Electromed, Inc. Appoints Brad Nagel as Chief Financial Officer\",\"datePublished\":\"2022-10-24T13:02:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/electromed-inc-appoints-brad-nagel-as-chief-financial-officer\\\/\"},\"wordCount\":443,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/electromed-inc-appoints-brad-nagel-as-chief-financial-officer\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/electromed-inc-appoints-brad-nagel-as-chief-financial-officer\\\/\",\"name\":\"Electromed, Inc. Appoints Brad Nagel as Chief Financial Officer - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2022-10-24T13:02:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/electromed-inc-appoints-brad-nagel-as-chief-financial-officer\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/electromed-inc-appoints-brad-nagel-as-chief-financial-officer\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/electromed-inc-appoints-brad-nagel-as-chief-financial-officer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Electromed, Inc. Appoints Brad Nagel as Chief Financial Officer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Electromed, Inc. Appoints Brad Nagel as Chief Financial Officer - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/electromed-inc-appoints-brad-nagel-as-chief-financial-officer\/","og_locale":"en_US","og_type":"article","og_title":"Electromed, Inc. Appoints Brad Nagel as Chief Financial Officer - Pharma Trend","og_description":"Accomplished medical device leader to fill key strategic role NEW PRAGUE, Minn.–(BUSINESS WIRE)–Electromed, Inc. (\u201cElectromed\u201d or the \u201cCompany\u201d) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that its Board of Directors has appointed Brad Nagel as the Company\u2019s Chief Financial Officer, effective November 14, 2022. Mr. Nagel brings to Electromed over ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/electromed-inc-appoints-brad-nagel-as-chief-financial-officer\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-24T13:02:33+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/electromed-inc-appoints-brad-nagel-as-chief-financial-officer\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/electromed-inc-appoints-brad-nagel-as-chief-financial-officer\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Electromed, Inc. Appoints Brad Nagel as Chief Financial Officer","datePublished":"2022-10-24T13:02:33+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/electromed-inc-appoints-brad-nagel-as-chief-financial-officer\/"},"wordCount":443,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/electromed-inc-appoints-brad-nagel-as-chief-financial-officer\/","url":"https:\/\/pharma-trend.com\/en\/electromed-inc-appoints-brad-nagel-as-chief-financial-officer\/","name":"Electromed, Inc. Appoints Brad Nagel as Chief Financial Officer - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2022-10-24T13:02:33+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/electromed-inc-appoints-brad-nagel-as-chief-financial-officer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/electromed-inc-appoints-brad-nagel-as-chief-financial-officer\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/electromed-inc-appoints-brad-nagel-as-chief-financial-officer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Electromed, Inc. Appoints Brad Nagel as Chief Financial Officer"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49980","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49980"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49980\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49980"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49980"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49980"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}